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A prospective evaluation of the feasibility and utility of
additional tools to obtain information from recently diagnosed
HIV infected patients
Abstract
QUESTION UNDER STUDY: Can additional information be obtained from recently HIV diagnosed
individuals? METHODS: A 1-year prospective Swiss study, including all newly diagnosed
HIV-infected patients. Information on circumstances of HIV infection was collected through physician-
and patient questionnaires and patient interviews. Information on timing of infection was linked with an
HIV-antibody avidity assay. RESULTS: Of 710 newly HIV diagnosed patients, 543 (76%) physician
questionnaires (PhyQ) and 145 (20%) patient questionnaires (PaQ) were returned. PhyQ required fewer
reminders (57% vs 28% spontaneous return). Patients whose doctors had returned the PhyQ were
comparable to total population group. In contrast, a strong bias towards well educated recently infected
Swiss men having sex with men (MSM) was seen in patients returning PaQ or agreeing to an interview.
83% of patients claimed that they knew the infection source and 85% infection place. Unprotected
sexual contact was the most frequently cited infection source (92%; n = 404). Men mainly claimed
occasional (43%) and women steady (61%) partners as the most likely source of HIVinfection. Serum
for timing of infection was available in 98% of patients. Recent infections (RI) were highest in MSM
(51%) and intravenous drug users (IDU, 54%). Compared to women, heterosexual men were more than
twice as likely to be diagnosed with a RI. CONCLUSION: Relevant additional information on
circumstances of HIV infection in newly diagnosed patients can easily be collected from treating
physicians. Collecting information from patients is not a feasible option, with the exception of
qualitative interviews in a selected group of patients.
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Question under study: Can additional informa-
tion be obtained from recently HIV diagnosed in-
dividuals?
Methods: A 1-year prospective Swiss study, in-
cluding all newly diagnosed HIV-infected pa-
tients. Information on circumstances of HIV in-
fection was collected through physician- and pa-
tient questionnaires and patient interviews. Infor-
mation on timing of infection was linked with an
HIV-antibody avidity assay. 
Results: Of 710 newly HIV diagnosed pa-
tients, 543 (76%) physician questionnaires
(PhyQ) and 145 (20%) patient questionnaires
(PaQ) were returned. PhyQ required fewer re-
minders (57% vs 28% spontaneous return). Pa-
tients whose doctors had returned the PhyQ were
comparable to total population group. In contrast,
a strong bias towards well educated recently in-
fected Swiss men having sex with men (MSM) was
seen in patients returning PaQ or agreeing to an
interview. 83% of patients claimed that they knew
the infection source and 85% infection place. Un-
protected sexual contact was the most frequently
cited infection source (92%; n = 404). Men mainly
claimed occasional (43%) and women steady
(61%) partners as the most likely source of HIV-
infection. Serum for timing of infection was avail-
able in 98% of patients. Recent infections (RI)
were highest in MSM (51%) and intravenous
drug users (IDU, 54%). Compared to women,
heterosexual men were more than twice as likely
to be diagnosed with a RI.
Conclusion: Relevant additional information
on circumstances of HIV infection in newly diag-
nosed patients can easily be collected from treat-
ing physicians. Collecting information from pa-
tients is not a feasible option, with the exception
of qualitative interviews in a selected group of pa-
tients.
Key words: HIV infection; feasibility; return rate;
circumstances; recent infections; partner type
Summary 
For 20 years, the Swiss Federal Office of Pub-
lic Health (SFOPH) has collected epidemiologi-
cal data on all newly diagnosed HIV infections in
Switzerland [1, 2]. These data are retrieved
through a primary physician questionnaire, in-
cluding questions on risk behaviour, stages and
clinical signs of HIV infection. However, detailed
information on circumstances, place, and timing
of HIV infection is missing. Personal observa-
tions from clinical cases suggest that it should be
possible to obtain additional data relevant for pre-
vention efforts both from treating physicians and
their patients. 
Knowledge on how and where HIV is cur-
rently being transmitted, and who has recently
been infected will provide important information
on current and future HIV transmission modes.
Thus, preventive efforts can be targeted or
adapted to address specific risk groups. The Swiss
Aids Transmission (CHAT) study was set up to
evaluate the feasibility and usefulness of collect-
ing additional detailed information from newly
diagnosed HIV patients, including an estimate on
timing of infection.
Various serological testing algorithms for re-
cent HIV seroconversion (STARHS) have been
developed in order to distinguish between recent
and older infections in HIV-infected individuals.
These tests make use of the fact that both the
concentration and affinity of HIV antibodies in
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early infection are lower than at later stages [3, 4].
One such test is the HIV-1 BED incidence en-
zyme immunoassay (EIA) (named after the
branched peptide sequences for HIV subtypes 
B, E, D used in the assay) [5].
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Methods
Study design: data were collected prospectively be-
tween July 05 and June 06. All patients >16 years of age
with a newly diagnosed HIV infection were included in
the study. The study was approved by the local ethical
committee.
Patient data were collected through the regular
SFOPH physician questionnaire (CF), an additional
CHAT physician questionnaire, a CHAT patient ques-
tionnaire, a patient interview and a blood sample. For
subsequent data merger, coordination and patient
anonymity, all patients were given an individualised
study-ID. 
I. The SFOPH physician questionnaire (CF): upon con-
firmation of an HIV infection, physicians are asked to
complete a complementary form (CF) distributed by the
SFOPH.
II. The CHAT physician questionnaire (PhyQ): physi-
cians were asked to complete an additional CHAT ques-
tionnaire. The PhyQ aimed at collecting additional infor-
mation on place (geographical location) circumstances
(partner type) of infection, as well as signs and symptoms
of primary HIV infection (PHI).
III. The CHAT patient questionnaire (PaQ): patients
were asked to fill in a separate questionnaire, which was
available in all three national languages (German, French,
Italian) and English. As a result, only patients fluent in
one of these 4-languages were able to complete this ques-
tionnaire. As all patients remained anonymous, treating
physicians were responsible for forwarding question-
naires to patients. The PaQ aimed at collecting additional
information on timing, circumstances (partner type, con-
dom use), sexual practices and signs and symptoms of pri-
mary HIV infection (PHI). The PaQ was available in a
long (14 pages) and a short version (6 pages). Both ques-
tionnaire versions were distributed (at random) to pa-
tients (questionnaires details under www.infekt.ch).
IV. A qualitative interview with consenting patients: on
PaQ, patients had the option to sign up for a personal in-
terview. Qualitative interviews were performed and eval-
uated by the „Fachhochschule Nordwestschweiz in
Olten, Hochschule für Soziale Arbeit, Institut für Inte-
gration und Partizipation”. Results are presented else-
where (only in German)
(http://www.bag.admin.ch/hiv_aids/00829/03471/in
dex.html?lang=de).
V. Estimation of timing of HIV infection – the HIV-1
BED Incidence assay: to supplement clinical information
on the timing of HIV infection, the HIV-1 BED inci-
dence assay (Calypte Biomedical Corporation, lake Os-
wego, Oregon, USA) was performed. The BED assay has
been used in several epidemiological studies [6–8]. Fur-
ther details on the use of the BED HIV-1 assay to esti-
mate incidence are available [9]. 
Patient blood samples were coded and tested batch-
wise at the Swiss National Centre for Retroviruses
(SNCR). Timing of infection was divided into recent in-
fections (<6 month upon HIV-diagnosis) and older infec-
tions (>6 month prior to diagnosis). Results of this sub
analysis have been published elsewhere [10].
Feasibility testing
Feasibility measurement was based on questionnaire
return rate and response rate to individual questions in
the questionnaire (completeness). A reminder system was
put in place, with a maximum of 2 reminders, for both
PhyQ and PaQ (in written). In both cases, physicians
were provided with a cross out option indicating reason(s)
for missing or not returned questionnaires. Feasibility of
laboratory testing regarding timing of infection was based
on the availability of additional blood samples.
Definition of Swiss nationality
For this study, foreigners with a permanent Swiss
residence >10 years were considered as “Swiss nationals”.
A similar exposure, to the Swiss HIV prevention cam-
paign was assumed. 
Results
Feasibility
During the study period, a total of 710 newly
diagnosed HIV infections were reported. Of
those, 543 PhyQ were completed and returned to
the CHAT study centre, 67 were returned empty
and 100 PhyQ were never returned. Reasons for
the 167 empty or missing PhyQ included physi-
cian refusal (65%), patient refusal (7%,), or physi-
cians’ inability to complete the questionnaire
(28%, eg, patient disappearance, living abroad,
not able, or deceased). Figure 1 shows a flow chart
of CHAT questionnaire return rate.
Return rate of PhyQ was clearly higher (76%,
543/710) than the PaQ (27%, 145/543). However,
the low return rate of PaQ includes 117 patients
who could not be reached for reasons of language.
In addition, considerably more effort was needed to
collect PaQ compared to PhyQ. In total 64%
(271/426) of PaQ had to be reminded at least once,
compared to 35% (246/710) PhyQ (figure 2).
After language screening, 426 (78%, 426/543)
PaQ could be sent to treating physicians who for-
warded them to the respective patient. Physicians
were later contacted regarding PaQ distribution.
361 (66%, 361/543) physicians confirmed having
forwarded the PaQ to patients (loss = 65 PaQ).
Reasons for not forwarding PaQ to patients were:
patient unknown (n=36), patient living abroad 
(n = 15), patient not able or deceased (n = 14). A
higher proportion of German speaking patients
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(46%, 97/212 received a German PaQ) completed
the PaQ as opposed to French (36%, 35/98 re-
ceived a French PaQ), Italian (32%, 6/19 received an
Italian PaQ), or English (22%, 7/32 received an
English PaQ). Questionnaire length had no effect
on return rate, with a 35% (29/82 received PaQ)
return rate for the short and 38% (32/85 received
PaQ) return rate for the longer version of the
questionnaire. A total of 47 patients (9%, 47/543)
patients agreed to an interview (11% of 426 total
questionnaires sent out).
Of the 543 PhyQ, 11 (2%) patients had no
BED test result. Reasons for missing BED results
were not enough serum (n = 3), samples never
reaching the NCR laboratory (n = 6), anonymous
testing (n = 2).
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CHAT population characteristics
Table 1 shows the demographics of newly di-
agnosed HIV patients during the study period.
The total patient population (n = 710) did not dif-
fer from the patient population included in the
CHAT survey (n = 543). Gender distribution, age,
transmission mode, nationality and timing of HIV
infection were comparable between the two
groups. In contrast, a clear selective trend was
seen in patients completing the PaQ (n = 145) or
agreeing to a personal interview (n = 47). Male
sex, higher level of education, homosexual trans-
mission and Swiss nationality were over repre-
sented in these two groups. In addition, patients
with a recent infection were more likely to fill in
the PaQ and agree to an interview (table 2).
The majority of newly diagnosed HIV infec-
tions occurred in Swiss men, through homosexual
transmission. On average, women were younger
than men at the time of diagnosis. The majority of
foreigners were of African origin, with a larger
PhyQ CHAT Inclusion 
n = 543  
(76%, 543/710) 
 Language screening: n = 117 (22%, 117/543) 
 Patient unknown: n = 65 (12%, 65/543) 
 Patient refusal: n = 216 (40%, 216/543) 
Patient agreeing to an 
interview 
n = 47  
(9%, 47/543) 
Newly diagnosed HIV 
infections with CHAT-ID 
n = 710 (100%) 
 Physician refusal: n = 100 (14%, 100/710) 
 Physician not able: n = 67 (9%, 67/710) 
Completed PaQ 
n = 145  
(27%, 145/543) 
 Patient refusal: n = 98 (68%, 98/145) 
3
3
3
3
3
3
Figure 1
Flow chart of CHAT
questionnaire return
rate.
Figure 2
Demonstrated addi-
tional effort needed
for the return of PhyQ
and PaQ.
Of the 710 physician
questionnaire (PhyQ)
sent out, 610 were
 returned (n = 543
completed, n = 67
empty). Of the 426
patient question-
naires (PaQ) sent out,
145 were returned 
to the CHAT study
centre. Spontaneous
return represented
those questionnaires
returned without any
preceding reminders. PhyQ PaQ
spontaneous
return
100
80
60
40
20
0
1 reminder
2 reminders
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All patients PhyQ PaQ Interview
n = 710 n = 543 n = 145 n = 47
Gender n; (% of total)
– men 489 (66%) 372 (69%) 128 (88%) 43 (91%)
– hetero men 133 (28%) 110 (30%) 18 (12%) 3 (6%)
– women 240 (34%) 169 (31%) 17 (12%) 4 (9%)
– unknown 2 (<1% 2 (<1%) – –
Age; mean (SD) years
– Total 38 (11) 38 (11) 40 (10) 39 (10)
– men 39 (11) 39 (11) 41 (11) 39 (10)
– women 36 (11) 35 (10) 37 (10) 31 (3)
Education n; (% of total)
– can read/write – 35 (6%) 4 (3%) 1 (2%)
– primary school. – 135 (22%) 19 (13%) 6 (13%)
– t/hs/uni1 – 318 (52%) 117 (81%) 39 (83%)
– unknown – 122 (20%) 5 (3%) 1 (2%)
Transmission source known: 
n, (% of total)
– Yes – 437 (83%) 122 (84%) 42 (89%)
– No – 91 (17%) 23 (16%) 5 (11%)
– No answer – 15 (3%) – –
Transmission mode
n; (% of total)
– heterosexual 317 (45%) 256 (47%) 34 (24%) 7 (15%)
– MSM 253 (36%) 218 (40%) 98 (71%) 37 (79%)
– IDU 57 (8%) 39 (7%) 5 (4%) 2 (4%)
– other/unknown 83(12%) 30(6%) 8 (6%) 1 (2%)
Nationality2 n; (% of total)
– Swiss 362 (51%) 320 (59%) 115 (79%) 40 (85%)
– hetero 126 (18%) 108 (20%) 24 (17%) 11 (11%)
– MSM3 178 (25%) 168 (31%) 82 (57%) 33 (70%)
– IDU4 40 (6%) 35 (5%) 4 (3%) 2 (2%)
– other/unknown 18 (2%) 15 (3%) 5 (3%) –
– Non-Swiss 302 (43%) 223 (41%) 30 (21%) 7 (15%)
– Europe – 54 (9%) 17 (12%) 5 (11%)
– Africa – 118 (20%) 9 (6%) 1 (2%)
– other – 42 (14%) 4 (3%) –
– unknown – 9 (2%) – 1 (2%)
– Unknown 46 (6%) – – –
1 Swiss nationality = all Swiss nationals and patients with permanent residence in Switzerland > 10 years;
2 t/hs/uni = traineeship / high school diploma / university degree; 3 MSM = men who have sex with men; 4 IDU = intravenous drug users
Table 1
Demographics of all
newly diagnosed HIV
patients during the
study period, with a
comparison between
patients with a com-
pleted physician
questionnaire (PhyQ),
patient questionnaire
(PaQ), or agreeing to
a personal interview.
percentage of foreigners in the female population
compared to men (79% vs. 50%, respectively) 
Additional information on timing, source and
place of HIV infection
Eighty percent of patients (437/543) said they
knew or had some idea as to how they became in-
fected with HIV. MSM were most knowledgeable,
with only 21 men (10%, of total MSM) claiming not
to know their infection source compared to 18%
and 26% among heterosexual men and women, re-
spectively. Among patients claiming to know the
infection source, 85% (373/437) indicated unpro-
tected sexual contact (SC) as the only possible in-
fection source. Patients indicating SC as a source of
HIV infection had the option of giving further
specifications as to the most likely “partner type”
involved during HIV transmission. A very high
percentage of patients (93%) were able to provide
this additional information. Among MSM and 
heterosexual men, occasional partners were the
most frequently mentioned source of infection, fol-
lowed by steady, anonymous, and unknown part-
ners. In women, the steady partner was by far the
most frequently mentioned risk partner, followed
by occasional, anonymous, and unknown partners
(table 3).
All patients answered the question on place of
HIV infection, with 84% (454/543) claiming to
know where they got infected. Switzerland was the
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most frequently cited place (57%; 259/454), with a
minority claiming HIV infection outside Switzer-
land. Swiss nationals in particular, indicated
Switzerland as the most likely place of infection
(72% of Swiss nationals). Of Swiss nationals in-
fected abroad, 70% (n = 55) indicated having been
on a tourist or business trip as compared to perma-
nent residence 30% (n = 24). In Switzerland, most
patients indicated a city (89%) as opposed to ag-
glomeration (5%) or more rural (6%) areas as the
most likely place of infection. The most frequently
cited cantons of HIV acquisition were the canton
of Zurich (79 reported cases), followed by Geneva
(n = 37) and Vaud (n = 24). 
Information on recentness of HIV infection
(BED assay) was available in 532 patients (with a
PhyQ). Results on recency are shown in table 2. RI
were particularly frequent in MSM (51%,
111/218), and IDU (54%, 21/39), with lower levels
in the heterosexual population (22%, 57/256). In
heterosexuals, men were more than twice as likely
to be diagnosed with a recent infection compared
to women (35%, 38/110 vs. 14%, 23/169). In addi-
tion, Swiss nationals were more than twice as likely
to be diagnosed with a recent infection compared
to foreigners. Most foreigners who reported hav-
ing been infected outside Switzerland were diag-
nosed with an old infection (92%, n = 103). In con-
trast, Swiss nationals infected outside Switzerland
during a holiday or business trip, showed a high
percentage of recent infections (65%, n = 55). 
S W I S S  M E D  W K LY 2 0 0 8 ; 13 8 ( 3 1 – 3 2 ) : 4 5 3 – 4 5 8  ·  w w w. s m w. ch
All patients PhyQ PaQ Interview
n = 597* n = 532* n = 145 n = 47
RI and source of infection
Total 223 (37%) 196 (37%) 70 (48%) 22 (47%)
– MSM (% of total MSM) –121 (52%) –111 (51%) –53 (54%) –
– Hetero (% of total hetero) –61 (22%) –57 (22%) –13 (38%) –
– IDU (% of total IDU) –27 (57%) –21 (54%) –2 (40%) –
– other / unknown (% of total o/u) –14 (32%) –7 (25%) –2 (25%) –
RI and nationality**
Total CH with BED results 332 314 – –
– Swiss with RI –162 (49%) –152 (48%) – –
(% of total CH with BED)
Total foreigners with BED results 253 218 – –
– Foreigners with RI –56 (22%) –44 (20%) – –
(% of total foreigners with BED)
RI and gender n (% of total 
hetero with BED)
– hetero men –38 (32%) –36 (33%) –7 (39%) –
– hetero women –23 (12%) –21 (15%) –6 (38%) –
* BED results (timing of infection) were not available in all patients. Total sample size is smaller than for demographics (table 1)
** Swiss nationality = all Swiss nationals and patients with permanent residence in Switzerland >10 years 
Infection route: unprotected sexual contact # patients (%)
Partner type MSM Hetero. men Women 
Steady 45 (24%) 26 (30%) 62 (61%)
Occasional 86 (45%) 36 (41%) 29 (29%)
Anonymous 37 (20%) 18 (21%) 2 (2%)
Unknown/ no response 22 (12%) 7 (8%) 7 (7%)
Total patients (n) 190 87 100
Table 2
Recent infections (RI),
nationality and gen-
der in newly diag-
nosed HIV patients,
with a comparison
between patients
with a completed
physician question-
naires (PhyQ), patient
questionnaire (PaQ),
or agreeing to a per-
sonal interview.* 
BED results (timing
of infection) were not
available in all pa-
tients. Total sample
size is smaller than
for demographics
(table 1)
Table 3
Unprotected sexual
contact as a source of
HIV infection and dis-
tribution of partner
type(s) (steady, occa-
sional, anonymous,
unknown/no re-
sponse) as indicated
by patients on the
PhyQ.
Discussion
The CHAT study is the first study to collect in-
formation directly from newly HIV diagnosed pa-
tients. An unexpectedly high proportion of patients
answered the additional questions included in the
PhyQ and PaQ, confirming the feasibility of col-
lecting increased detailed information from newly
diagnosed HIV infected patients. This study shows
that patients were not only surprisingly aware of
how and where they might have been infected with
HIV, but were also able to provide further detailed
information regarding the most likely partner type
involved during HIV transmission. Nonetheless the
source of information highly determined return
rate with a better return rate for the PhyQ includ-
ing considerably fewer reminders. Surprisingly, for
the PaQ other factors besides total questionnaire
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length determined return rate in this population
group. Regional aspects and language seemed to
have a greater impact, with German speaking pa-
tients having the highest return rate compared to
French, Italian or English speaking patients. 
Despite a loss of 23% (n = 167), population
characteristics of patients with a completed PhyQ
were comparable to the total patient population
newly diagnosed with HIV. In contrast, returned
PaQ showed a strong bias towards well educated
Swiss homosexuals, making this source of informa-
tion considerably less representative. A handicap of
the PaQ was the necessity to screen for language,
discriminating against patients unable to speak one
of the Swiss national languages or English. 
For future systematic epidemiological monitor-
ing, the HIV-1 BED incidence assay was evaluated
as a potential tool for monitoring recent infections in
Switzerland. In this study, an additional blood test
was available for almost all patients, supporting the
feasibility of such a monitoring system. MSM and
IDU had an increased probability of being diagnosed
with a RI. This result is most probably driven by the
fact that practitioners are increasingly sensitised to
HIV screening in these groups. In contrast, migrants
mostly of African origin were more frequently diag-
nosed with an old infection, consistent with an HIV
acquisition prior to arriving in Switzerland. In het-
erosexuals, women were considerably less likely to be
diagnosed with a recent infection. A higher percent-
age of foreigners in the female population might
partly explain for this difference. In addition, a short
holiday or business trip might increase HIV risk be-
haviour. These patients might very well have been
aware of an increase in HIV risk behaviour during
their journey, initiating an HIV screening test after
returning to Switzerland. 
As expected, cities such as Zurich, Geneva and
Lausanne were designated as high-risk areas, with
more rural areas being less important. 
In conclusion, information regarding timing,
source and place of HIV infection in newly diag-
nosed individuals can easily be obtained from re-
porting physicians. Based on findings from this
study, the physician CF distributed by the
SFOPH has been adapted to include this addi-
tional information. Ability to monitor potential
changes in HIV transmission trends could thus be
improved. As a result, prevention messages can
more easily be adapted or tailored to current or
future risk behaviour, specifically focusing on as-
pects such as gender, nationality, specific risk situ-
ations and geographical areas. 
Timing of HIV infection can be used as a
novel standard or quality control for the ability of
the health care system to detect patients in the ear-
liest and most infectious stages of HIV-infection
[11]. This would not only optimise patient care but
would also insure the spread of presently impor-
tant HIV prevention messages at an early stage of
infection, when transmission risk is at its highest.
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